Episode
What Oncology Pharmacists Need to Know About Targeting BCMA in Early Relapsed/Refractory Myeloma
- Published
- Jul 13, 2026
- Duration seconds
- 1713
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/decera-clinical-education-oncology-podcast-1302999/episodes/what-oncology-pharmacists-need-to-know-about-targeting-bcma-in-early-relapsed-refractory-myeloma/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/decera-clinical-education-oncology-podcast-1302999/what-oncology-pharmacists-need-to-know-about-targeting-bcma-in-early-relapsed-refractory-myeloma.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
This podcast includes a discussion on what oncology pharmacists need to know about the role, efficacy, and safety of agents targeting BCMA in the personalized care of patients with multiple myeloma after disease progression on 1 or 2 previous lines of therapy.